NRx Pharmaceuticals, Inc. (NASDAQ: NRXP), a biopharmaceutical company focused on neuroplastic therapies for depression, PTSD and related conditions, announced on October 15, 2026 that it…
October 15, 2026
October 15, 2026
LanzaTech Backs New LanzaJet Financing as Freedom Pines Moves Toward Commercial Growth
LanzaTech Global, Inc. (NASDAQ: LNZA), a carbon recycling company that converts waste carbon into fuels and chemicals, is backing a new round of financing for…
October 15, 2026
Vanda Pauses VQW-765 Program After Phase III Social Anxiety Study Misses Primary Endpoint
Vanda Pharmaceuticals Inc. (NASDAQ: VNDA), a commercial-stage company with approved treatments in psychiatry, sleep and neurology, provided an update on October 14, 2026 on VQW-765,…
October 15, 2026
Recursion Raises $200 Million as FAP Data and a Sanofi Option Move Its Pipeline Forward
Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX), a clinical-stage biotechnology company that uses an AI-enabled design platform to discover drugs, announced on October 15, 2026 an oversubscribed…
October 14, 2026
Electrovaya Expects Record Fiscal 2026 Revenue as Jamestown Plant and ElvaPulse Line Near Launch
Electrovaya Inc. (NASDAQ: ELVA), a lithium-ion battery technology and manufacturing company, provided a business update on October 14, 2026 that points to record revenue for…
October 14, 2026
Viking Therapeutics Launches Phase 3 SUNRISE Program for Once-Daily Oral VK2735 in Obesity
Viking Therapeutics, Inc. (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, announced on October 14, 2026 that it has started the…
October 13, 2026
NioCorp Puts All Planned Elk Creek Production Under Long-Term Sales Agreements With New Traxys Deal
NioCorp Developments Ltd. (NASDAQ: NB), a U.S. developer of critical minerals, announced on October 13, 2026 a binding 15-year definitive agreement with Traxys North America…
October 12, 2026
Draganfly Forms a Dedicated U.S. Defense Subsidiary With Former Acting Navy Secretary Thomas Modly as Chairman
Draganfly Inc. (NASDAQ: DPRO), a developer of drone solutions and unmanned systems, announced on October 12, 2026 the establishment of Draganfly Defense USA, Inc., a…
October 12, 2026
Pagaya Closes Its 100th Asset-Backed Securitization as 2026 Issuance Tops $10 Billion
Pagaya Technologies Ltd. (NASDAQ: PGY), a technology company that uses AI to deliver consumer credit products for lenders and investors, announced on October 12, 2026…
October 12, 2026
NervGen Doses First Participant in Phase 3 RESTORE Study of NVG-291 for Chronic Spinal Cord Injury
NervGen Pharma Corp. (NASDAQ: NGEN), a late-stage clinical biopharmaceutical company developing treatments for spinal cord injury (SCI), announced on October 12, 2026 that the first…
October 12, 2026
Enovix Tops Third-Quarter Revenue Guidance as Drone and Defense Pipeline Reaches $216 Million
Enovix Corporation (NASDAQ: ENVX), a developer and manufacturer of advanced lithium-ion batteries, reported preliminary third-quarter results on October 12, 2026. Preliminary, unaudited revenue came in…
October 08, 2026
Byrna Lifts Margins and Retools Its Marketing as Fiscal Third-Quarter Revenue Declines
Byrna Technologies Inc. (NASDAQ: BYRN), a personal defense technology company that makes less-lethal personal security products, reported results on October 8, 2026 for its fiscal…